Institutional Ownership Neuro Sense Therapeutics Ltd. (NRSN)
This table provides information about the institutional ownership of Neuro Sense Therapeutics Ltd. (NRSN). We have compiled data on the 8 institutions that hold shares in the stock, with a total of 225,356 shares, which have been reported (via 13F filing form) to have a value of $247,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Cantor Fitzgerald, L. P.
New York, NY |
Nov 14, 2024 Q3 2024 |
79,492
shares
|
$87,441
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Xtx Topco LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
45,996
shares
|
$50,595
0.0% of portfolio
|
Q3 2024
Added 40.88%
|
|
|
Meitav Dash Investments LTD
|
Oct 28, 2024 Q3 2024 |
40,000
shares
|
$44,000
0.0% of portfolio
|
Q2 2024
Reduced 20.0%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
34,280
shares
|
$37,708
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Commonwealth Equity Services, LLC
|
Oct 18, 2024 Q3 2024 |
12,625
shares
|
$13,887
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
11,963
shares
|
$13,159
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Cwm, LLC
|
Oct 08, 2024 Q3 2024 |
1,000
shares
|
$1,100
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|